Latest Cyclotron Stories
LITTLETON, Mass., June 22, 2011 /PRNewswire/ -- Still River Systems, Inc.
AUGUSTA, Ga., June 14, 2011 /PRNewswire/ -- Cardinal Health today opened its first cyclotron facility in the state of Georgia, further expanding its nationwide capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease. Cyclotrons are critical to the manufacturing process for Positron Emission Tomography (PET) molecular imaging agents, one of the fastest-growing areas of nuclear medicine.
VICTORIA, British Columbia and DALLAS, February 18, 2011 /PRNewswire/ -- UNIT4 Business Software (http://www.unit4software.com),the world's leading provider of business software for fast changing organizations, today announced an agreement worth over $1 million dollars with TRIUMF (http://www.triumf.ca), Canada's national laboratory for particle and nuclear physics.
BERLIN, November 23, 2010 /PRNewswire-FirstCall/ -- Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG).
LITTLETON, Mass., Oct. 26 /PRNewswire/ -- Still River Systems' groundbreaking proton therapy system is entering the final phase of installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St.
BOCA RATON, Fla., Aug. 16 /PRNewswire/ -- Electrone Americas Ltd., Co.
Researchers have taken one more step toward understanding the unique and often unexpected properties of graphene, a two-dimensional carbon material that has attracted interest because of its potential applications in future generations of electronic devices.
LITTLETON, Mass., May 14 /PRNewswire/ -- Still River Systems, Inc. announces successful clinical beam extraction from the first production unit of the world's smallest high-energy proton therapy accelerator.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.